Evidence map›Paper›PMID 29078772›Full record

ArticleBMC urology2017

Canadian Men's perspectives about active surveillance in prostate cancer: need for guidance and resources.

Margaret Fitch, Kittie Pang, Veronique Ouellet, Carmen Loiselle, Shabbir Alibhai, Simone Chevalier, Darrel E Drachenberg, Antonio Finelli, Jean-Baptiste Lattouf, Simon Sutcliffe and 4 more

Open access · goldAbstract read
In one paragraph

Article in BMC urology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
2.0field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Treatment decision-making in men with localized prostate cancer living in a remote area: A cross-sectional, observational study.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Margaret FitchSunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada.
Kittie PangSunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, ON, Canada.
Veronique OuelletInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada.
Carmen LoiselleMcGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada.
Shabbir AlibhaiUniversity Health Network, 610 University Ave, Toronto, ON, Canada.
Simone ChevalierMcGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada.
Darrel E DrachenbergManitoba Prostate Centre, 675 McDermot Ave, Winnipeg, MB, Canada.
Antonio FinelliUniversity Health Network, 610 University Ave, Toronto, ON, Canada.
Jean-Baptiste LattoufInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada.
Simon SutcliffeTerrry Fox Research Institute, 675 West 10th Avenue, Vancouver, BC, Canada.
Alan SoVancouver Prostate Centre, 2660 Oak St, Vancouver, BC, Canada.
Simon TanguayMcGill University and McGill University Health Centre, 1001 Decarie Blvd, Montreal, QC, Canada.
Fred SaadInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada. fred.saad@umontreal.ca.ORCID http://orcid.org/0000-0003-2986-5617
Anne-Marie Mes-MassonInstitut du cancer de Montréal and Centre de recherche du Centre hospitalier de l'Université de Montréal, 900 St Denis St, Montreal, QC, Canada.
Centre Hospitalier de l’Université de Montréal · CAMcGill University Health Centre · CASunnybrook Health Science Centre · CAUniversity Health Network · CATerry Fox Research Institute · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn prostate cancer, men diagnosed with low risk disease may be monitored through an active surveillance. This research explored the perspectives of men with prostate cancer regarding their decision-making process for active surveillance to identify factors that influence their decision and assist health professionals in having conversations about this option.

methodsFocus group interviews (n = 7) were held in several Canadian cities with men (N = 52) diagnosed with prostate cancer and eligible for active surveillance. The men's viewpoints were captured regarding their understanding of active surveillance, the factors that influenced their decision, and their experience with the approach. A content and theme analysis was performed on the verbatim transcripts from the sessions.

resultsPatients described their concerns of living with their disease without intervention, but were reassured by the close monitoring under AS while avoiding harmful side effects associated with treatments. Conversations with their doctor and how AS was described were cited as key influences in their decision, in addition to availability of information on treatment options, distrust in the health system, personality, experiences and opinions of others, and personal perspectives on quality of life.

conclusionsMen require a thorough explanation on AS as a safe and valid option, as well as guidance towards supportive resources in their decision-making.

Indexed as

Decision MakingProstatic NeoplasmsWatchful WaitingAgedAged, 80 and overCanadaFocus GroupsHumansMaleMiddle AgedPopulation SurveillanceProstate-Specific AntigenQualitative ResearchQuality of LifeProstate-Specific AntigenActive surveillanceDecisions makingFocus groupLow risk diseaseProstate cancer

Identifiers

PMID29078772
PMCPMC5658971
OpenAlexW2765733087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.